Boston Scientific adds Dr. Cheryl Pegus to its Board of Directors

– USA, MA –  Boston Scientific Corporation (NYSE: BSX) today announced the election of Dr. Cheryl Pegus (MD, MPH) to its Board of Directors, effective immediately.

“We are pleased to expand our board of directors with a highly respected, visionary clinical leader. Cheryl is passionate about the role health care innovation can play in improving outcomes and expanding health care access, and we look forward to her contributions as Boston Scientific continues to grow and serve more patients around the world,” said Chairman and CEO,  Mike Mahoney.

About Dr. Cheryl Pegus

Dr. Cheryl Pegus has more than 25 years of clinical and business leadership experience, most recently serving as a partner at Morgan Health focused on improving the quality, affordability, and equity of health care. Before that, Dr. Pegus was EVP of Health & Wellness at Walmart, president of Consumer Solutions CMO for Cambia Health Solutions, and CMO at Walgreens. Before joining Walgreens, Dr. Pegus was the general manager and CMO for SymCare Personalized Health Solutions, Inc., a diabetes-focused division of Johnson & Johnson, and held roles at Pfizer and Aetna.

Dr. Cheryl Pegus began her career in private practice as a cardiologist and previously served as board chair for the Association of Black Cardiologists. She serves on the board of the American Heart Association and is co-founder of A New Beat, an organization dedicated to improving the cardiovascular health and careers of women and underrepresented minorities.

Dr. Pegus received her B.A. from Brandeis University, her M.D. from Weill Cornell Medical College, and her M.P.H. from Columbia University Mailman School of Public Health.

About Boston Scientific

Boston Scientific transforms lives through innovative medical technologies that improve the health of patients around the world. As a global medical technology leader for more than 40 years, we advance science for life by providing a broad range of high-performance solutions that address unmet patient needs and reduce the cost of healthcare. Our portfolio of devices and therapies helps physicians diagnose and treat complex cardiovascular, respiratory, digestive, oncological, neurological, and urological diseases and conditions.

SOURCE: www.bostonscientific.com

- DisclaimerNews, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.